Clinical assessment of treatment efficacy of herbal formulation in reducing hypertension and tocompare with standard medication.

ational Innovation Foundation India0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•Age group 18-70 years , Either Sex
•Essential hypertension : Mild (Systolic BP- 140 to 159mm Hg and /or Diastolic BP- 90 to 99 mmHg) and Moderate (Systolic 160- 179mm of Hg / or Diastolic BP- 100-109)

•1.History of coronary artery disease, myocardial infarction, stroke, transient ischemic attack, any revascularization procedure, congestive heart failure, or hemodynamically significant carotid or peripheral arterial disease
•2.Pregnant / Breast feeding women.
•3.Women having hormonal contraception or having no effective birth control measure.
•4.Diabetes mellitus type I and II
•5.As per the opinion of investigator ,any other Surgical /medical illness not mentioned in the protocol - which may place patients at high risk due to their participation in the study OR may lead to their noncompliance to the protocol.
•6.Use of other concomitant medications â?? adrenergic drugs or steroids that may affect blood pressure.
•7.Hypersensitivity to any of the test drug
•8. Patients with kidney or liver disease

发起方

ational Innovation Foundation India